Ownership history in Parallel Advisors, LLC · 27 quarters on record
This page tracks every 13F SEC filing in which Parallel Advisors, LLC reported a position in CORCEPT THERAPEUTICS INC COM (CORT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 3,879,141 | +7,689 | +0.2% | 2.47% | $135.0M | $34.80 |
| 2025 Q3 | ADDED | 3,871,452 | +329 | +0.0% | 5.89% | $321.8M | $83.11 |
| 2025 Q2 | REDUCED | 3,871,123 | -101,293 | -2.5% | 5.68% | $284.1M | $73.40 |
| 2025 Q1 | ADDED | 3,972,416 | +142,784 | +3.7% | 4.95% | $219.6M | $114.22 |
| 2024 Q4 | ADDED | 3,829,632 | +15,908 | +0.4% | 4.34% | $193.0M | $50.39 |
| 2024 Q3 | REDUCED | 3,813,724 | -2,036 | -0.1% | 4.15% | $176.5M | $46.28 |
| 2024 Q2 | ADDED | 3,815,760 | +83 | +0.0% | 3.18% | $124.0M | $32.49 |
| 2024 Q1 | ADDED | 3,815,677 | +47,432 | +1.3% | 2.60% | $96.1M | $25.19 |
| 2023 Q4 | ADDED | 3,768,245 | +44,762 | +1.2% | 3.63% | $122.4M | $32.48 |
| 2023 Q3 | REDUCED | 3,723,483 | -3,082 | -0.1% | 3.38% | $101.4M | $27.25 |
As of 2025 Q4 — sorted by position size